Skip to main content
. 2019 Jun;8(3):736–751. doi: 10.21037/tcr.2019.04.10

Table 6. Pathological type distribution in gene-mutated patients.

Mutated genes ADC SCC
Cases Rate (%) Cases Rate (%)
EGFR 47 95.92 2 4.08
ALK 6 85.71 1 14.29
ROS1 3 75.00 1 25.00
MET 3 75.00 1 25.00
ERBB2 (Her2) 4 100.00 0 0
BRAF 2 100.00 0 0
KRAS 6 75.00 2 25.00

ADC, adenocarcinoma; SCC, squamous cell carcinoma.